Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents

Jin Cai; Hongtao Wei; Kwon Ho Hong; Xiaoqing Wu; Xi Zong; Meng Cao; Peng Wang; Lushen Li; Chunlong Sun; Bo Chen; Gaoxing Zhou; Junqing Chen; Min Ji

doi:10.1016/j.bmc.2015.04.028

Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents

Jin Cai, Hongtao Wei, Kwon Ho Hong, Xiaoqing Wu, Xi Zong, Meng Cao, Peng Wang, Lushen Li, Chunlong Sun, Bo Chen, Gaoxing Zhou, Junqing Chen, Min Ji

Medicinal Chemistry

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

Abstract In our study, three series of hydroxamate, 2-aminobenzamide, and trifluoromethyl ketone analogues have been designed and synthesized. The synthesized compounds were investigated for their in vitro antiproliferative activities using the MTT-based assay against three human cancer cell lines including A549, NCI-H661, and U937. Most analogues exhibited higher antiproliferative activities against human acute myeloid leukemia cell U937 than the other two human lung cancer cell lines. Furthermore, the compounds were examined against HDAC1, 2, and 8 isoforms. Docking study of compounds 6h, 9b, and 10a suggested that they might bind tightly to the binding pocket of HDAC2 and/or HDAC8. The results suggest that these compounds might have potential as lead compounds for the development of anti-tumor drugs with HDACs inhibitory activities.

Original language	English (US)
Article number	12240
Pages (from-to)	3457-3471
Number of pages	15
Journal	Bioorganic and Medicinal Chemistry
Volume	23
Issue number	13
DOIs	https://doi.org/10.1016/j.bmc.2015.04.028
State	Published - 2015

Bibliographical note

Funding Information:
This work is supported by The Fundamental Research Funds for the Central Universities ( 2242014R30019 ), Technology Supporting Program of Jiangsu Province ( BE2012657 ), and National Basin Research Program of China (No. 2011CB933503 ). We thank the Minnesota Supercomputing Institute for their support for our molecular modeling study.

Keywords

2-Aminobenzamide
Antiproliferative activity
Docking simulation
Histone deacetylases (HDAC)
Hydroxamate
Trifluoromethyl ketone

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.bmc.2015.04.028

Cite this

Cai, J., Wei, H., Hong, K. H., Wu, X., Zong, X., Cao, M., Wang, P., Li, L., Sun, C., Chen, B., Zhou, G., Chen, J., & Ji, M. (2015). Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents. Bioorganic and Medicinal Chemistry, 23(13), 3457-3471. [12240]. https://doi.org/10.1016/j.bmc.2015.04.028

Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents. / Cai, Jin; Wei, Hongtao; Hong, Kwon Ho; Wu, Xiaoqing; Zong, Xi; Cao, Meng; Wang, Peng; Li, Lushen; Sun, Chunlong; Chen, Bo; Zhou, Gaoxing; Chen, Junqing; Ji, Min.

In: Bioorganic and Medicinal Chemistry, Vol. 23, No. 13, 12240, 2015, p. 3457-3471.

Research output: Contribution to journal › Article › peer-review

Cai, J, Wei, H, Hong, KH, Wu, X, Zong, X, Cao, M, Wang, P, Li, L, Sun, C, Chen, B, Zhou, G, Chen, J & Ji, M 2015, 'Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents', Bioorganic and Medicinal Chemistry, vol. 23, no. 13, 12240, pp. 3457-3471. https://doi.org/10.1016/j.bmc.2015.04.028

Cai, Jin ; Wei, Hongtao ; Hong, Kwon Ho ; Wu, Xiaoqing ; Zong, Xi ; Cao, Meng ; Wang, Peng ; Li, Lushen ; Sun, Chunlong ; Chen, Bo ; Zhou, Gaoxing ; Chen, Junqing ; Ji, Min. / Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents. In: Bioorganic and Medicinal Chemistry. 2015 ; Vol. 23, No. 13. pp. 3457-3471.

@article{2d4c4054b630455da4aec6800e741569,

title = "Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents",

abstract = "Abstract In our study, three series of hydroxamate, 2-aminobenzamide, and trifluoromethyl ketone analogues have been designed and synthesized. The synthesized compounds were investigated for their in vitro antiproliferative activities using the MTT-based assay against three human cancer cell lines including A549, NCI-H661, and U937. Most analogues exhibited higher antiproliferative activities against human acute myeloid leukemia cell U937 than the other two human lung cancer cell lines. Furthermore, the compounds were examined against HDAC1, 2, and 8 isoforms. Docking study of compounds 6h, 9b, and 10a suggested that they might bind tightly to the binding pocket of HDAC2 and/or HDAC8. The results suggest that these compounds might have potential as lead compounds for the development of anti-tumor drugs with HDACs inhibitory activities.",

keywords = "2-Aminobenzamide, Antiproliferative activity, Docking simulation, Histone deacetylases (HDAC), Hydroxamate, Trifluoromethyl ketone",

author = "Jin Cai and Hongtao Wei and Hong, {Kwon Ho} and Xiaoqing Wu and Xi Zong and Meng Cao and Peng Wang and Lushen Li and Chunlong Sun and Bo Chen and Gaoxing Zhou and Junqing Chen and Min Ji",

note = "Funding Information: This work is supported by The Fundamental Research Funds for the Central Universities ( 2242014R30019 ), Technology Supporting Program of Jiangsu Province ( BE2012657 ), and National Basin Research Program of China (No. 2011CB933503 ). We thank the Minnesota Supercomputing Institute for their support for our molecular modeling study. ",

year = "2015",

doi = "10.1016/j.bmc.2015.04.028",

language = "English (US)",

volume = "23",

pages = "3457--3471",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Limited",

number = "13",

}

TY - JOUR

T1 - Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents

AU - Cai, Jin

AU - Wei, Hongtao

AU - Hong, Kwon Ho

AU - Wu, Xiaoqing

AU - Zong, Xi

AU - Cao, Meng

AU - Wang, Peng

AU - Li, Lushen

AU - Sun, Chunlong

AU - Chen, Bo

AU - Zhou, Gaoxing

AU - Chen, Junqing

AU - Ji, Min

N1 - Funding Information: This work is supported by The Fundamental Research Funds for the Central Universities ( 2242014R30019 ), Technology Supporting Program of Jiangsu Province ( BE2012657 ), and National Basin Research Program of China (No. 2011CB933503 ). We thank the Minnesota Supercomputing Institute for their support for our molecular modeling study.

PY - 2015

Y1 - 2015

N2 - Abstract In our study, three series of hydroxamate, 2-aminobenzamide, and trifluoromethyl ketone analogues have been designed and synthesized. The synthesized compounds were investigated for their in vitro antiproliferative activities using the MTT-based assay against three human cancer cell lines including A549, NCI-H661, and U937. Most analogues exhibited higher antiproliferative activities against human acute myeloid leukemia cell U937 than the other two human lung cancer cell lines. Furthermore, the compounds were examined against HDAC1, 2, and 8 isoforms. Docking study of compounds 6h, 9b, and 10a suggested that they might bind tightly to the binding pocket of HDAC2 and/or HDAC8. The results suggest that these compounds might have potential as lead compounds for the development of anti-tumor drugs with HDACs inhibitory activities.

AB - Abstract In our study, three series of hydroxamate, 2-aminobenzamide, and trifluoromethyl ketone analogues have been designed and synthesized. The synthesized compounds were investigated for their in vitro antiproliferative activities using the MTT-based assay against three human cancer cell lines including A549, NCI-H661, and U937. Most analogues exhibited higher antiproliferative activities against human acute myeloid leukemia cell U937 than the other two human lung cancer cell lines. Furthermore, the compounds were examined against HDAC1, 2, and 8 isoforms. Docking study of compounds 6h, 9b, and 10a suggested that they might bind tightly to the binding pocket of HDAC2 and/or HDAC8. The results suggest that these compounds might have potential as lead compounds for the development of anti-tumor drugs with HDACs inhibitory activities.

KW - 2-Aminobenzamide

KW - Antiproliferative activity

KW - Docking simulation

KW - Histone deacetylases (HDAC)

KW - Hydroxamate

KW - Trifluoromethyl ketone

UR - http://www.scopus.com/inward/record.url?scp=84937403780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937403780&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2015.04.028

DO - 10.1016/j.bmc.2015.04.028

M3 - Article

C2 - 25953722

AN - SCOPUS:84937403780

VL - 23

SP - 3457

EP - 3471

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 13

M1 - 12240

ER -

Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents

Abstract

Bibliographical note

Keywords

UN SDGs

Access

Other files and links

Fingerprint

Cite this